Mark Thomas

3.6k total citations
89 papers, 2.5k citations indexed

About

Mark Thomas is a scholar working on Molecular Biology, Oncology and Organic Chemistry. According to data from OpenAlex, Mark Thomas has authored 89 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Molecular Biology, 14 papers in Oncology and 11 papers in Organic Chemistry. Recurrent topics in Mark Thomas's work include Calcium signaling and nucleotide metabolism (8 papers), Estrogen and related hormone effects (7 papers) and Hormonal Regulation and Hypertension (6 papers). Mark Thomas is often cited by papers focused on Calcium signaling and nucleotide metabolism (8 papers), Estrogen and related hormone effects (7 papers) and Hormonal Regulation and Hypertension (6 papers). Mark Thomas collaborates with scholars based in United Kingdom, United States and South Africa. Mark Thomas's co-authors include Barry V. L. Potter, Howard E. Gendelman, Stephen Mills, Victor Vitvitsky, Ruma Banerjee, Anuja Ghorpade, Isiah M. Warner, Gabor Patonay, Anna‐Mart Engelbrecht and Peter M. Fischer and has published in prestigious journals such as Journal of Biological Chemistry, Angewandte Chemie International Edition and PLoS ONE.

In The Last Decade

Mark Thomas

87 papers receiving 2.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark Thomas United Kingdom 28 1.1k 574 242 239 188 89 2.5k
David Haigh United Kingdom 28 1.8k 1.7× 1.1k 1.8× 282 1.2× 256 1.1× 124 0.7× 53 3.1k
Motonari Uesugi Japan 34 2.4k 2.3× 708 1.2× 245 1.0× 431 1.8× 185 1.0× 131 3.6k
Bhaskar C. Das United States 32 1.4k 1.4× 798 1.4× 170 0.7× 322 1.3× 181 1.0× 111 3.4k
František Hubálek Denmark 28 1.7k 1.6× 868 1.5× 143 0.6× 115 0.5× 220 1.2× 55 3.3k
Laura Fumagalli Italy 26 1.3k 1.2× 450 0.8× 141 0.6× 113 0.5× 161 0.9× 106 2.6k
Michael S. Malamas United States 27 1.5k 1.4× 1.2k 2.0× 497 2.1× 295 1.2× 170 0.9× 71 3.3k
Aaron B. Miller United States 26 1.5k 1.4× 543 0.9× 640 2.6× 485 2.0× 82 0.4× 47 2.8k
Mark A. Levy United States 33 2.0k 1.9× 449 0.8× 229 0.9× 644 2.7× 225 1.2× 100 3.4k
Rodolfo Márquez United Kingdom 27 1.7k 1.6× 1.2k 2.1× 119 0.5× 332 1.4× 285 1.5× 94 3.3k

Countries citing papers authored by Mark Thomas

Since Specialization
Citations

This map shows the geographic impact of Mark Thomas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Thomas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Thomas more than expected).

Fields of papers citing papers by Mark Thomas

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Thomas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Thomas. The network helps show where Mark Thomas may publish in the future.

Co-authorship network of co-authors of Mark Thomas

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Thomas. A scholar is included among the top collaborators of Mark Thomas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Thomas. Mark Thomas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dodson, Charlotte A., Stephen E. Flower, & Mark Thomas. (2023). A Multidisciplinary Team-Based Classroom Exercise for Small Molecule Drug Discovery. Journal of Chemical Education. 100(9). 3320–3332. 3 indexed citations
2.
Edinburgh, Robert M., et al.. (2020). The day-to-day reliability of peak fat oxidation and FATMAX. European Journal of Applied Physiology. 120(8). 1745–1759. 29 indexed citations
3.
Zhang, Irene, Mark Thomas, Barclay T. Stewart, et al.. (2020). Validation of a low-cost simulation strategy for burn escharotomy training. Injury. 51(9). 2059–2065. 6 indexed citations
4.
5.
Thomas, Mark, et al.. (2018). Synthetic cADPR analogues may form only one of two possible conformational diastereoisomers. Scientific Reports. 8(1). 15268–15268. 3 indexed citations
6.
Sureshan, Kana M., Andrew M. Riley, Mark Thomas, et al.. (2012). Contribution of Phosphates and Adenine to the Potency of Adenophostins at the IP3Receptor: Synthesis of All Possible Bisphosphates of Adenophostin A. Journal of Medicinal Chemistry. 55(4). 1706–1720. 22 indexed citations
7.
Thomas, Mark & Barry V. L. Potter. (2011). Crystal Structures of 11β-Hydroxysteroid Dehydrogenase Type 1 and Their Use in Drug Discovery. Future Medicinal Chemistry. 3(3). 367–390. 31 indexed citations
8.
Wood, Paul M., L. W. Lawrence Woo, Mark Thomas, et al.. (2011). Aromatase and Dual Aromatase‐Steroid Sulfatase Inhibitors from the Letrozole and Vorozole Templates. ChemMedChem. 6(8). 1423–1438. 56 indexed citations
9.
Su, Xiangdong, Nigel Vicker, Mark Thomas, et al.. (2011). Discovery of Adamantyl Heterocyclic Ketones as Potent 11β‐Hydroxysteroid Dehydrogenase Type 1 Inhibitors. ChemMedChem. 6(8). 1439–1451. 8 indexed citations
10.
Su, Xiangdong, Fabienne Pradaux, Mark Thomas, et al.. (2010). Discovery of Adamantyl Ethanone Derivatives as Potent 11β‐Hydroxysteroid Dehydrogenase Type 1 (11β‐HSD1) Inhibitors. ChemMedChem. 5(7). 1026–1044. 14 indexed citations
11.
Thomas, Mark, Priscilla Rupali, Andrew Woodhouse, & R. B. Ellis‐Pegler. (2009). Good outcome with trimethoprim 10 mg/kg/day-sulfamethoxazole 50 mg/kg/day for Pneumocystis jirovecii pneumonia in HIV infected patients. Scandinavian Journal of Infectious Diseases. 1–7. 2 indexed citations
13.
James, John, Michael G. Palumbo, & Mark Thomas. (2007). Consumption smoothing among working-class American families before social insurance. Oxford Economic Papers. 59(4). 606–640. 6 indexed citations
14.
Engelbrecht, Anna‐Mart, et al.. (2007). Proanthocyanidin from grape seeds inactivates the PI3-kinase/PKB pathway and induces apoptosis in a colon cancer cell line. Cancer Letters. 258(1). 144–153. 121 indexed citations
15.
Kontopidis, George, Campbell McInnes, I.W. McNae, et al.. (2006). Differential Binding of Inhibitors to Active and Inactive CDK2 Provides Insights for Drug Design. Chemistry & Biology. 13(2). 201–211. 49 indexed citations
16.
Thomas, Mark & Campbell McInnes. (2006). Structure-based discovery and optimization of potential cancer therapeutics targeting the cell cycle.. PubMed. 9(4). 273–8. 3 indexed citations
17.
Thomas, Mark, Chandra Verma, Susan M. Boyd, & K Brocklehurst. (1995). The structural origins of the unusual specificities observed in the isolation of chymopapain M and actinidin by covalent chromatography and the lack of inhibition of chymopapain M by cystatin. Biochemical Journal. 306(1). 39–46. 11 indexed citations
20.
Warner, Isiah M., Gabor Patonay, & Mark Thomas. (1985). MULTIDIMENSIONAL LUMINESCENCE MEASUREMENTS. Analytical Chemistry. 57(3). 463A–483A. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026